GEN had an effect on improving acetaminophen (APAP)-induced liver damage and hepatic fibrosis in mice by reducing the expressions of connective tissue growth factor, TNF-α and IL-6 (Song H. et al., 2018). The gene discussed is CCN2; the disease is Hepatic fibrosis.